OptimizeRx and DeepIntent Partner
Analysis based on 6 articles · First reported May 21, 2026 · Last updated May 21, 2026
The partnership between OptimizeRx and DeepIntent is expected to positively impact the healthcare advertising market by providing life sciences marketers with more efficient and privacy-safe ways to reach healthcare providers. This collaboration could lead to increased revenue and market share for both OptimizeRx and DeepIntent, potentially boosting their stock performance and valuation.
OptimizeRx, a healthcare technology company, announced a partnership with DeepIntent, a healthcare demand-side platform (DSP). DeepIntent will be the first DSP to integrate OptimizeRx's proprietary electronic health record (EHR) network into its healthcare advertising platform. This collaboration aims to provide life sciences marketers with an easier way to activate advertising within healthcare provider (HCP) workflows, using programmatic tools. The integration addresses the growing demand for privacy-safe advertising solutions tied to real clinical workflows and is expected to be available in Q3 2026. Both Steve Silvestro, CEO of OptimizeRx, and Lisa Kopp Johnson, Chief Revenue Officer of DeepIntent, highlighted the benefits of this partnership for delivering timely and relevant information to support informed care decisions and better patient outcomes.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard